openPR Logo
Press release

In-Depth Analysis of the Smart Biopsy Devices Market: Growth Opportunities, Key Trends, and Forecast 2025-2034

03-05-2025 12:36 PM CET | Health & Medicine

Press release from: The Business Research Company

Smart Biopsy Devices Market Size

Smart Biopsy Devices Market Size

What industry-specific factors are fueling the growth of the smart biopsy devices market?
The growth of the smart biopsy devices market is projected to be driven by the increasing incidence of cancer. Cancer entails a broad spectrum of diseases that can occur in almost any body tissue or organ when rogue cells proliferate without control, breach their usual constraints, and either spread to other organs or intrude into nearby body parts. This rise in cancer cases has heightened the need for precise and targeted tissue samples, leading to the development and improvement of smart biopsy tools with enhanced molecular, imaging, and precision capabilities for assist diagnosis and treatment planning. As reported by the World Health Organization in January 2024, it is anticipated that the number of new cancer cases will exceed 35 million by 2050, up 77% from the estimated 20 million cases and 9.7 million deaths in 2022. Therefore, the surge in cancer cases is fueling the growth of the smart biopsy device market.

Get Your Smart Biopsy Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

What Is the projected market size and growth rate for the smart biopsy devices market?
The market size for smart biopsy devices has seen robust growth in the previous years. The market is projected to increase from $2.85 billion in 2024 to $3.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The upswing in the historical phase can be credited to the rise in cancer incidents, the popularity of minimally invasive procedures, advancements in medical equipment, and enhanced diagnostic precision.

The market for smart biopsy devices is projected to experience substantial growth in the forthcoming years, with its value expected to reach $4.05 billion by 2029, representing a compound annual growth rate (CAGR) of 7.5%. This projected growth during the forecast period is due to several factors such as the expansion of personalized medicine, advancements in imaging technologies, an increase in biopsies for biomarker analysis, the introduction of new market players, and improved data connectivity. Notable trends for the forecasted period comprise robot-aided biopsies, artificial intelligence-supported biopsy assistance, the invention of wireless biopsy instruments, and the advent of portable and handheld devices along with real-time guidance systems.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What are the emerging trends shaping the future of the smart biopsy devices market?
Significant players in the smart biopsy device market are driving innovations by creating advanced products such as breast biopsy markers, which enhance the accuracy and proficiency of breast cancer diagnostic procedures. These markers are crafted to precisely identify the spot of a tissue sample collected during a biopsy, providing a map for future treatments and ensuring potential malignancies are closely monitored in the correct area. For example, in August 2022, medical devices firm based in the US, Mammotome, unveiled the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy device employs a two-stage process to deliver precise, high-quality tissue samples and is frequently used alongside ultrasound for accurate, safe, and efficient diagnosis of breast cancer. The system can be integrated with advanced breast biopsy markers, providing clinicians with a well-rounded and inventive solution for ultrasound-guided breast biopsies.

What major market segments define the scope and growth of the smart biopsy devices market?
The smart biopsy devices market covered in this report is segmented -

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays
3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

Which region dominates the smart biopsy devices market?
North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the smart biopsy devices industry growth?
Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Is Covered In The Smart Biopsy Devices Global Market Report?

• Market Size Forecast: Examine the smart biopsy devices market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the smart biopsy devices market for a structured understanding.
• Key Players Overview: Analyze major players in the smart biopsy devices market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the smart biopsy devices market.
• Segment Contributions: Evaluate how different segments drive overall growth in the smart biopsy devices market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the smart biopsy devices market.
• Industry Challenges: Identify potential risks and obstacles affecting the smart biopsy devices market.
• Competitive Landscape: Review strategic developments in the smart biopsy devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-Depth Analysis of the Smart Biopsy Devices Market: Growth Opportunities, Key Trends, and Forecast 2025-2034 here

News-ID: 3899198 • Views:

More Releases from The Business Research Company

Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth? In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 Billion in 2029
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025? In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis Report
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025? The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025? The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.

All 5 Releases


More Releases for Biopsy

Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430 This latest report researches the industry structure, sales, revenue,
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 . Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from